[1] 李丽娇,杨素娟,许梦婷.妊娠期肝内胆汁淤积症的发病危险因素分析[J].中国妇幼保健,2020,35(3).413-415. [2] 潘玥,李娥琼.不同孕周妊娠期肝内胆汁淤积症生化指标差异与围产儿预后的分析[J].中国计划生育和妇产科,2019,11(1):53-55. [3] 中华医学会妇产科学分会产科学组.妊娠期肝内胆汁淤积症诊疗指南(2015)[J].中华妇产科杂志,2015,50(7):481-485. [4] 王桂青,剧洽,陈新云.胆汁酸、肝酶、α- 羟丁酸脱氢酶水平对妊娠期肝内胆汁淤积症患者围产结局的预测价值[J].中国妇产科临床杂志,2018,19(3):257-258. [5] 赵苏青. 妊娠内肝内胆汁淤积症与红细胞分布宽度的关系[J].中国药物与临床,2021,21(9):3. [6] 张弘,唐禹馨,张金玲.妊娠期肝内胆汁淤积症孕妇代谢水平变化情况及与新生儿不良结局的相关性[J].中国妇幼保健,2021,36(10):2225-2227. [7] 周兰,漆洪波,罗欣.早发型妊娠期肝内胆汁淤积症患者的临床生化特点及围产结局分析[J].中华妇产科杂志2013,48(1):20-24. [8] SMITH D D,ROOD K M.Intrahepatic cholestasis of pregnancy[J].Clin Obstet Gynecol,2020,63(1):134-151. [9] KASIRER Y,BIN-NUN A,RAVEH A,et al.SMOFlipid protects preterm neonates against perinatal nutrition-associated cholestasis[J].Am J Perinatol,2019,36(13):1382-1386. [10] HAGENBECK C,HAMZA A,KEHL S,et al.Management of Intrahepatic Cholestasis of Pregnancy:Recommendations of the Working Group on Obstetrics and Prenatal Medicine-Section on Maternal Disoeders[J].Geburtshilfe Frauenheilkd,2021,81(8):922-939. [11] BRITES D.Intrahepatic cholestasis of pregnancy:changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid[J].Ann Hepatol,2002,1(1):20-8. |